Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis Virus”

4,332 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,332 results

Not applicableStudy completedNCT02556307
What this trial is testing

The Effectiveness of Peginterferon Alfa-2a (Pegasys) and Ribavirin Treatment in Slovenian Hepatitis C (HCV) Patients

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 270
Testing effectiveness (Phase 2)Study completedNCT03546621
What this trial is testing

A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D

Who this might be right for
Chronic Hepatitis D Infection With Hepatitis B
Hepatera Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT04684914
What this trial is testing

HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
Altimmune, Inc. 87
Not applicableWithdrawnNCT00571714
What this trial is testing

Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142811
What this trial is testing

Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection

Who this might be right for
Viral Hepatitis
Vir Biotechnology, Inc. 100
Large-scale testing (Phase 3)Study completedNCT00006164
What this trial is testing

Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment

Who this might be right for
Chronic Hepatitis cCirrhosis, LiverFibrosis, Liver+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,050
Post-approval studies (Phase 4)Study completedNCT00558493
What this trial is testing

Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Bukwang Pharmaceutical 100
Post-approval studies (Phase 4)Study completedNCT06922643
What this trial is testing

Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital

Who this might be right for
Chronic Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 100
Not applicableEnded earlyNCT02568540
What this trial is testing

C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study

Who this might be right for
Hepatitis C
Boston Children's Hospital 155
Large-scale testing (Phase 3)Study completedNCT04193189
What this trial is testing

B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

Who this might be right for
HIV InfectionHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 638
Post-approval studies (Phase 4)Study completedNCT00179413
What this trial is testing

Study of Long-term Peg Intron vs. Colchicine in Non-responders.

Who this might be right for
Hepatitis C VirusAdvanced FibrosisCirrhosis
Beth Israel Deaconess Medical Center 549
Post-approval studies (Phase 4)Study completedNCT00657657
What this trial is testing

Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 29
Not applicableStudy completedNCT03415334
What this trial is testing

Effect of Implementation Of Outreach Behavioral Change Program for HCV Elimination

Who this might be right for
Hepatitis C and B VIRUS Screening, Awareness and Behavior Assessment and Evaluation for All Inhabitants Above Twelve Years of Al Othmaneya Village
National Research Centre, Egypt 3,575
Not applicableStudy completedNCT01355107
What this trial is testing

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease

Who this might be right for
Hepatitis CLiver CirrhosisCarcinoma, Hepatocellular
University Hospital Freiburg 32
Not applicableWithdrawnNCT01645007
What this trial is testing

Prevalence of Hepatitis B Infection in the Galilee Region, Israel

Who this might be right for
Hepatitis B
Western Galilee Hospital-Nahariya
Not applicableUnknownNCT04980664
What this trial is testing

Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of China

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 2,000
Post-approval studies (Phase 4)Study completedNCT03823911
What this trial is testing

Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

Who this might be right for
Cardiovascular DiseasesHepatitis CHiv
University of Maryland, Baltimore 87
Large-scale testing (Phase 3)UnknownNCT02897596
What this trial is testing

Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients

Who this might be right for
Hepatitis CHIV
Fundacion Clinic per a la Recerca Biomédica 62
Testing effectiveness (Phase 2)Study completedNCT02349048
What this trial is testing

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C Virus
Janssen Research & Development, LLC 68
Very early researchWithdrawnNCT03702218
What this trial is testing

Hepatitis C Positive Donor Into Hepatitis C Negative Recipients

Who this might be right for
Hepatitis C
University of Maryland, Baltimore
Load More Results